Merit Medical Systems Inc (MMSI)
76.69
+2.58
(+3.48%)
USD |
NASDAQ |
May 01, 16:00
76.69
0.00 (0.00%)
After-Hours: 20:00
Merit Medical Systems SG&A Expense (Quarterly): 95.75M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 95.75M |
September 30, 2023 | 86.85M |
June 30, 2023 | 100.93M |
March 31, 2023 | 90.14M |
December 31, 2022 | 83.24M |
September 30, 2022 | 89.78M |
June 30, 2022 | 85.49M |
March 31, 2022 | 84.02M |
December 31, 2021 | 76.63M |
September 30, 2021 | 86.47M |
June 30, 2021 | 91.56M |
March 31, 2021 | 81.02M |
December 31, 2020 | 79.93M |
September 30, 2020 | 72.22M |
June 30, 2020 | 66.77M |
March 31, 2020 | 78.81M |
December 31, 2019 | 82.09M |
September 30, 2019 | 86.94M |
June 30, 2019 | 79.98M |
March 31, 2019 | 78.27M |
December 31, 2018 | 75.63M |
September 30, 2018 | 66.38M |
June 30, 2018 | 69.10M |
March 31, 2018 | 64.91M |
December 31, 2017 | 59.24M |
Date | Value |
---|---|
September 30, 2017 | 54.72M |
June 30, 2017 | 57.41M |
March 31, 2017 | 57.77M |
December 31, 2016 | 45.84M |
September 30, 2016 | 53.20M |
June 30, 2016 | 43.65M |
March 31, 2016 | 41.70M |
December 31, 2015 | 40.94M |
September 30, 2015 | 39.20M |
June 30, 2015 | 39.32M |
March 31, 2015 | 36.88M |
December 31, 2014 | 36.21M |
September 30, 2014 | 36.33M |
June 30, 2014 | 38.59M |
March 31, 2014 | 36.76M |
December 31, 2013 | 33.64M |
September 30, 2013 | 31.35M |
June 30, 2013 | 31.56M |
March 31, 2013 | 32.13M |
December 31, 2012 | 33.47M |
September 30, 2012 | 28.88M |
June 30, 2012 | 30.21M |
March 31, 2012 | 29.55M |
December 31, 2011 | 28.03M |
September 30, 2011 | 25.71M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
66.77M
Minimum
Jun 2020
100.93M
Maximum
Jun 2023
84.14M
Average
84.02M
Median
Mar 2022
SG&A Expense (Quarterly) Benchmarks
Becton Dickinson & Co | 1.213B |
Integer Holdings Corp | 46.93M |
Abbott Laboratories | 2.959B |
Insulet Corp | 212.80M |
West Pharmaceutical Services Inc | 86.70M |